On the one hand, there is dead silence in the media about safe and effective
integrative treatments that could save the lives of millions of cancer
patients. On the other hand, whenever a group of "politically correct"
researchers are busily spending their grant money on futuristic projects,
the media is there to report faithfully on their theories and experiments.
Although some of the information on this web site is brand new, all are
rooted in the work of scientists like Nobel-prize winner Otto Warburg,
Albert Szent-Gyorgyi, and Linus Pauling, among many others. It is one of
the major characteristics of the groups that control the allopathic medical
establishment to dismiss or ignore the groundbreaking work of these intellectual
giants.
I wanted to draw a parallel between the obscenely expensive "research"
carried out by well-positioned "scientists", and the work of
courageous and honest practitioners, quietly curing cancer patients of
"incurable" conditions.
Phoney cancer research is one of the most lucrative and never-ending occupations
in the allopathic establishment. It is so profitable, and it became such
a beloved tradition among our esteemed medical leaders, that it seems almost
anti-American to speak out against it.
Here is a tutorial to prepare the cancer patient for chemotherapy. What
is not mentioned anywhere in the tutorial is that chemotherapy is an obsolete,
profit-driven nightmare that should have been banned a long time ago. There
are a number of more effective, although much less profitable treatments
available, that are perfectly safe and have no side effects.
http://www.chemoready.ca/TutorialPatient/frame1.jsp
The focus of ChemoReady is on helping to prepare you for
chemotherapy. Other resources provide more comprehensive information on side
effects, including: www.cancer.gov, www.oncolink.upenn.edu and www.cancer.ca.
All resource links provided in this tutorial will be included in your ChemoReady
Plan for easy reference.
Please tell me more about
these possible physical side effects:
|
Please tell me more about
these possible physical side effects:
|
|
Chemotherapy can affect the bone marrow, where all blood cells are produced.
If your white blood cell count drops to a certain level, you may develop
neutropenia. Neutropenia is one of the most serious common side effects
of chemotherapy because:
- If left untreated, it may lead to fever and life-threatening infection.
- It may cause chemotherapy dose delays or reductions.
Your cancer team will monitor your white blood cells during chemotherapy.
Your risk for developing neutropenia depends on certain factors such as your
age, type of chemotherapy and whether or not you've had neutropenia before.
|
|
|
Whether or not you lose your hair and how much you lose will depend on your
chemotherapy treatment. Hair generally starts to fall out within 7 to 21 days of
starting certain types of chemotherapy.
What can you do if you lose your hair?
Hair loss can have a strong psychological impact. It may be comforting to
know that it grows back one to two months after treatment ends, often thicker
than before. You can consider wigs, scarves, hats or a shorter hairstyle – do
whatever feels most comfortable.
|
|
|
Mouth sores are common and usually occur several days after you start
chemotherapy.
What can you do to help prevent mouth sores?
Before starting chemotherapy, have a dental check-up and cleaning. After you
start chemotherapy, begin rinsing your mouth with alcohol-free mouthwashes, use
soft toothbrushes and eat soft foods. If you develop mouth sores, talk to your
cancer team about treatment options.
|
|
I used the word, nightmare.
Was it an exaggeration?
 |
Ask your Cancer Team?
What about reading the reports first, and then ask them?
|
Genetic Factor Predicts Prognosis In Brain Tumor Patients
Science Daily — PLoS ONE has just
published a study which defines a gene locus on chromosome 1 that predicts
prognosis of brain tumor patients and may even set the basis for the development
of more efficient drugs to combat brain cancer. Clinical and basic researchers
from the University Hospital Basel, Switzerland, the Heinrich Heine University
Düsseldorf, Germany, and the Emory University Atlanta, USA have defined the
Notch2 gene as candidate gene for brain tumor development. The study was
coordinated by Adrian Merlo, neurosurgeon at the University Hospital Basel.
There are several treatment that are able to eliminate brain tumors safely
and rapidly. One of them is used on a daily basis in a cancer clinic in
the USA with great success. Some of the procedures were published in peer
reviewed medical journals. Don't these scientists read the medical literature?
CNN Medical News
June 28, 2007: 04:00 PM EST
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the final results
from a multicenter Phase II clinical trial sponsored by GlaxoSmithKline
(GSK), which evaluated ispinesib in patients with locally advanced or metastatic
breast cancer. Ispinesib is a novel small molecule inhibitor of kinesin
spindle protein (KSP), a mitotic kinesin essential for proper cell division.
Ispinesib has arisen from a broad strategic collaboration between Cytokinetics
and GlaxoSmithKline (GSK) to discover, develop and commercialize novel
small molecule therapeutics targeting human mitotic kinesins for applications
in the treatment of cancer and other diseases.
Breast cancer is already curable with safe, effective and non-patentable
treatments, although nobody will get rich from them.
Hair test may reveal breast cancer
An Australian company is on the brink of launching a world-first test that
can detect breast cancer by close examination of a patient's hair.
The test is based on an Australian university discovery that breast cancer
changes the molecular structure of hair, and the difference can be picked up
using sophisticated X-ray technology.
The company, Fermiscan, is running a trial of 2,000 women that compares the
hair test to a mammogram and said it should be finished within the next two
months.
Breast cancer can be detected with a gentle, benign and FDA approved test
years before it becomes clinically observable. The test is widely available
in the USA and elsewhere, but it is never mentioned by oncologists and
in the media. By the way, comparing the hair test to a mammogram? Here
is some useful information about mammography. Perhaps the company, Fermiscan, should read it.
|
